§Why CasetextPricing

Rydex Technologies LLC v. Hospira Inc.

MOTION For Supplemental Markman Submissions -

1 Cited authority

  1. Teva Pharm. United States, Inc. v. Sandoz, Inc.

    574 U.S. 318 (2015)   Cited 1,223 times   68 Legal Analyses
    Holding that, where no subsidiary factual dispute exists, appellate court reviews district court's construction of patent de novo